Nebulized Lidocaine
Nebulized Lidocaine is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison Between Different Ways for Using Lidocaine During FB
Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children
A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine
Nebulized Lidocaine, Dexmedetomedine and Their Combination in Direct Laryngoscopy Surgery
Clinical Trials (6)
Comparison Between Different Ways for Using Lidocaine During FB
Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children
A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine
Nebulized Lidocaine, Dexmedetomedine and Their Combination in Direct Laryngoscopy Surgery
Comparison of Topical and Nebulized Anesthesia in Patients Undergoing Esophago-Gastro-Duodenoscopy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6